AstraZeneca (AZN.O) said its collaboration with Oracle (ORCL.N) will cover core therapeutic areas including oncology, cardiovascular, renal and metabolic diseases, respiratory, immunology and rare diseases.

2026-10-20

AstraZeneca (AZN.O) said its collaboration with Oracle (ORCL.N) will cover core therapeutic areas including oncology, cardiovascular, renal and metabolic diseases, respiratory, immunology and rare diseases.